Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells

Cell Biology International

Volumn 35, Issue 8, 2011, Pages 799-802

  Li, Zhuo Ri ^a   Wu, Yi Fei ^b   Ma, Chun Yang ^c,d,e   Nie, Shen Dan ^b   Mao, Xian Hai ^b   Shi, Yong Zhong ^b  

^a HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

^b Hunan Provincial People's Hospital   (China)

^c HAINAN MEDICAL UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

C Myc; Cholangiocarcinoma; Invasion

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MYC PROTEIN; MYC PROTEIN, HUMAN;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BIOSYNTHESIS; CANCER INVASION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; STOP CODON; TUMOR CELL LINE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; CODON, NONSENSE; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFECTION;

EID: 84855181844     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110099     Document Type: Article

References (22)

1. Albihn A, Johnsen JI, Henriksson MA. MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res 2010;107:163-224.
2. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999;19:1-11.
3. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R. Non-transcriptional control of DNA replication by c-Myc. Nature 2007;448(7152):445-51.
4. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R. Genetic alteration of the c-Myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 1986;83:4834-8.
5. Han S, Kim HY, Park K, Cho HJ, Lee MS, Kim HJ, Kim YD. c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci 1999;14:526-30.
6. Ishii H, Gobe G, Kawakubo Y, Sato Y, Ebihara Y. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins. Histopathology 2001;38:111-9.
7. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366(9493):1303-14.
8. Kimura S, Maekawa T, Hirakawa K, Murakami A, Abe T. Alterations of c-Myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res 1995;55(6):1379.
9. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-67.
10. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-Myc oncogene in human lung cancer cell lines. Nature 1983;306:194-6.
11. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004;66(3):167-79.
12. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006;3(1):33-42.
13. Prakobwong S, Khoontawad J, Yongvanit P, Pairojkul C, Hiraku Y, Sithithaworn P, Pinlaor P, Aggarwal BB, Pinlaor S. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int J Cancer 2011;129(1):88-100.
14. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24(2):115-25.
15. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a casecontrol study. Gastroenterology 2005;128:620-6.
16. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005;41(1):5-15.
17. Tang HH, Chang S, Wang XW, Huang Y, Gong XJ, Zhou J. Diagnostic and surgical therapeutic features of extrahepatic bile duct carcinoma without jaundice. World J Gastroenterol 2004;10(20):3060-1.
18. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-20.
19. Tokumoto N, Ikeda S, Ishizaki Y, Kurihara T, Ozaki S, Iseki M, Shimizu Y, Itamoto T, Arihiro K, Okajima M, Asahara T. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol 2005;27(4):973-80.
20. Wang ZR, Liu W, Smith ST, Parrish RS, Young SR. c-Myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp Mol Pathol 1999;66:140-8.
21. Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and c-Myc in the development of gastric cancer. World J Gastroenterol 2001;7:403-6.
22. Zhang GX, Gu YH, Zhao ZQ, Xu SF, Zhang HJ, Wang HD, Hao B. Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases. World J Gastroenterol 2004;10:1759-62.